Leiva RA, Bergersen BM, Finbraten AK, Sandvei PK, et al. High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway. Scand J Gastroenterol 2022 Sep 5:1-5. doi: 10.1080/00365521.2022.2118555.
PMID: 36063075